Resolution is everything. When developing molecular cytogenetic assays for microdeletion syndromes, fluorescence in situ hybridization (FISH) is preferred because conventional chromosomal karyotyping simply cannot see these tiny genetic lesions. Its optical limit—roughly 5 to 10 megabases—means submicroscopic deletions fall into a blind spot. FISH, by contrast, deploys fluorescently labeled, locus-specific DNA probes that physically light up the target region, confirming the presence or absence of a deletion with single‑cell clarity.
Microdeletion syndromes are defined by chromosomal losses below the detection threshold of standard G-banded karyotyping. FISH is the definitive diagnostic tool because it offers the high spatial resolution and molecular specificity required to visualize these otherwise invisible anomalies directly in patient cells, often without the need for cell culture.
The Resolution Gap: Why Karyotyping Cannot Detect Microdeletions
Conventional karyotyping provides a valuable genome-wide view of large structural and numerical changes. But its fundamental physical limitation makes it blind to the small deletions that cause a range of severe developmental disorders.
The Optical Limit of G-Banding
Standard G-banded karyotyping relies on chromatin compaction patterns visualized under a light microscope. The practical resolution ceiling is between 5 and 10 megabases (Mb). Any structural change smaller than that—no matter how clinically devastating—is simply indistinguishable from normal banding.
Microdeletions Are Invisible by Design
The very pathology of microdeletion syndromes sits below this limit. Classic syndromes like DiGeorge (22q11.2), Williams (7q11.23), Prader-Willi/Angelman (15q11-q13), Cri‑du‑chat (5p-), and Wolf‑Hirschhorn (4p-) involve deletions typically ranging from a few hundred kilobases to around 3 Mb. In a karyotype, these regions look completely normal. A lab relying solely on karyotyping would report a normal result, missing the diagnosis entirely.
How FISH Bridges the Resolution Gap
FISH sidesteps the optical constraints of banding by using direct molecular hybridization. It replaces the blur of chromatin staining with the crisp, bright signal of a fluorescent probe tailor-made for the genomic address in question.
Locus-Specific Hybridization
FISH probes are composed of fluorophore-labeled DNA fragments, typically 60 to 200 kilobases in length, that are complementary to the exact deletion-prone region. These probes will hybridize only to their specific target locus on the chromosome. The resulting fluorescent spot resolves structural detail down to approximately 2 Mb—well within the range needed to catch a microdeletion.
The Dual-Probe Strategy for Absolute Diagnostic Confidence
Clever probe design elevates FISH from a simple “spot check” to a robust diagnostic system. A standard microdeletion FISH assay includes two key elements:
- A target region probe specific to the deletion locus.
- A control probe that binds to a stable region on the same chromosome (often the centromere).
This dual‑color approach provides an internal reference. A normal cell shows two signals for the control probe and two for the target probe. A cell with a deletion shows two control signals but only one target signal, delivering an unambiguous, quantifiable result that bypasses subjective banding interpretation.
Rapid Answers from Non-Dividing Cells
One of FISH’s most powerful strategic advantages is that it does not require living, dividing cells. Conventional karyotyping mandates a 3‑ to 7‑day cell culture to harvest metaphase spreads—a step that often fails with fragile tumor biopsies or provides unwelcome delays in anxious prenatal or neonatal settings. Interphase FISH hybridizes directly to nuclei in uncultured amniocytes, blood lymphocytes, or even formalin‑fixed, paraffin‑embedded (FFPE) tissue. This capability slashes turnaround time and eliminates the most common point of assay failure in clinical flow.
Understanding the Trade-offs
FISH is not a universal replacement for karyotyping. Its power is precision, but precision requires a specific target. Recognizing these limitations is essential for building the right diagnostic workflow.
A Highly Targeted, Not a Genome-Wide, View
FISH is fundamentally a hypothesis-driven test. The probe will only interrogate the single genomic address it was designed for. It cannot survey the rest of the genome for unexpected anomalies, novel deletions, or copy‑number variants elsewhere. A negative FISH result for a 22q11.2 deletion, for example, does not rule out another genetic cause for the patient’s phenotype.
Prior Knowledge is a Prerequisite
To develop a FISH assay, you must already know which microdeletion you are looking for. FISH is ideal for confirming a suspected clinical diagnosis, not for discovery. If a clinician is facing an undiagnosed developmental disorder with no clear syndrome suspicion, a genome‑wide microarray or karyotype would be the logical first step, followed by FISH for validation.
Making the Right Choice for Your Diagnostic Goal
The decision between FISH and karyotyping hinges entirely on the clinical question being asked. Use the following framework to guide your assay‑development strategy.
- If your primary focus is rapid, definitive confirmation of a specific, suspected microdeletion syndrome: FISH is the gold standard. Its combination of locus‑specific resolution, dual‑probe internal controls, and compatibility with non‑dividing cells provides the fastest path to an actionable diagnosis.
- If your primary focus is an initial genome-wide screen for large structural anomalies, aneuploidies, or unknown causes of developmental delay: Begin with conventional karyotyping or a chromosomal microarray. If a cryptic deletion is then suspected, design a targeted FISH assay to serve as the reflex confirmation and to test family members.
In the world of cytogenetics, what you see is what you can diagnose—and for microdeletion syndromes, FISH transforms invisible genetic gaps into the brilliant, countable signals that give clinicians and families a definitive answer.
Summary Table:
| Feature | Conventional Karyotyping | FISH (Fluorescence In Situ Hybridization) |
|---|---|---|
| Resolution Limit | 5 – 10 Mb (misses submicroscopic losses) | ~60 – 200 kb target probes (resolves < 3 Mb deletions) |
| Detection Strategy | Genome-wide G-banding pattern analysis | Specific fluorescent locus-specific & control probes |
| Sample Requirements | Requires live, cultured dividing cells (3–7 days) | Compatible with non-dividing/interphase cells & FFPE |
| Diagnostic Role | Unbiased screening for large structural shifts | Targeted, high-confidence confirmation of specific syndromes |
Are you developing advanced molecular cytogenetic or diagnostic assays? CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to premium IVD raw materials, technical services, and expert consulting—supporting every stage of your product journey from concept to clinic. Contact us today to optimize your assay performance!